fenofibrate has been researched along with Cancer of Endometrium in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Excerpt | Relevance | Reference |
---|---|---|
"A nude mouse model of endometrial carcinoma was used to investigate the effect of fenofibrate in vivo but failed to show consistent inhibition of tumour growth." | 1.33 | In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer. ( Charnock-Jones, DS; Holland, CM; Saidi, SA; Smith, SK, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Miao, C | 1 |
Chen, Y | 1 |
Fang, X | 1 |
Zhao, Y | 1 |
Wang, R | 1 |
Zhang, Q | 1 |
Saidi, SA | 1 |
Holland, CM | 1 |
Charnock-Jones, DS | 1 |
Smith, SK | 1 |
2 other studies available for fenofibrate and Cancer of Endometrium
Article | Year |
---|---|
Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach.
Topics: Computational Biology; Endometrial Neoplasms; Female; Fenofibrate; Gene Regulatory Networks; Humans; | 2022 |
In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Res | 2006 |